期刊文献+

载脂蛋白E基因-219G/T多态与阿尔茨海默病的相关研究 被引量:2

A study on the relation between the apolipoprotein E promoter-219G/T polymorphism and Alzheimers disease.
下载PDF
导出
摘要 目的 探讨上海地区汉族人群中载脂蛋白E基因 (ApoE)启动子区 2 1 9G/T多态与阿尔茨海默病(Alzheimer’sdisease,AD)发病风险的关系。方法 采用聚合酶链式反应 (PCR)和限制性片段长度多态 (RELP)方法 ,于 1 0 4例AD患者和 1 1 1例正常人中检测 2 1 9G/T多态各基因型及基因频率的分布。按比值比 (OR)作疾病关联分析。结果 ①AD患者与正常对照人群之间不存在 2 1 9G/T多态各等位基因和基因型频率分布的差异 (P值均大于0 0 5) ;②按ApoEε4基因分层后 ,无论是ε4型人群还是非ε4型人群中都不存在AD患者与正常对照人群间的多态分布的差异 (P值均大于 0 0 5) ;③ 2 1 9G/T多态各基因型的分布不影响AD与ApoEε4等位基因的关联。结论 上海地区汉族人群中 ,ApoE基因启动子区 2 1 Objective To explore the relationship of the apolipoprotein E(ApoE) promoter 219G/T polymorphism and Alzheimers disease in a Shanghai Han population. Methods We detected the ApoE promoter 219G/T polymorphism in 104 AD cases and 111 healthy subjects with polymerase chain reaction(PCR) method and restriction fragment length polymorphism(RELP)genotyping technique. Then we compared the differences of polymorphic distribution and the odds ratio for association analysis. Results We found no distribution differences of the ApoE promoter 219G/T polymorphism between AD cases and controls( P >0 05). No association between AD and 219G/T variants was observed either in ε4 or non ε4 subgroups, furthermore, the ε4 allele showed remarkable association with AD in all three 219G/T genotypes. Conclusions In our Shanghai Han samples, the ApoE gene promoter 219G/T polymorphism is not correlated to the risk for AD.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2002年第5期321-323,共3页 Chinese Journal of Nervous and Mental Diseases
基金 上海市卫生局青年课题资助项目 (编号 :994Y12 )
关键词 阿尔茨海默病 载脂蛋白E 启动子多态 关联 AD 聚合酶链反应 限制性片段长度多态方法 Alzheimers disease Apolipoprotein E Promoter polymorphism Association
  • 相关文献

参考文献10

  • 1江三多,冯国鄞,吴晓东,林嗣萃,顾牛范,金通观,康伟民,高哲石,任大明,江开达.Alzheimer病与载脂蛋白E ε_4等位基因的关联分析[J].中华精神科杂志,1996,29(1):15-18. 被引量:39
  • 2Artiga MJ, Bullido MJ, Sastre I, et al. Allelic polymorphism in the transciptional regulatory region of apolipoptotein E gene. FEBS Lett, 1998,421(2):105.
  • 3Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. ApoE and Alzheimer Disease Meta Analysis Consortium. JAMA, 1997,278(16): 1349.
  • 4Taddei K, Ckarnette R, Gandy SE, et al. Increased plasma apolipoprotein E (ApoE) levels in Alzheimer's disease. Neurosci Lett, 1997,223(1):56.
  • 5Yamada T, Kondo A, Takamatsu J, et al. Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. J Neurol Sci, 1995, 129(1):56.
  • 6Garcia MA, Vazquez J, Gimenez C, et al. Transcription factor Ap-2 regulates human apolipoprotein E gene expression in astrocytoma cells. J Neurosci, 1996,16(23) :7550.
  • 7Lamber JC, Pasquier F, Cottel D, et al. A new polymorphism in the ApoE promoter associated with risk of developing Alzheimer's disease.Hum Mol Genet, 1998,7(3) :533.
  • 8Halimi G, Duplan L, Bideau C, et al. Association of ApoE promoter but not A2M polymorphism with risk of developing Alzheimer's disease. Neuroreport, 2000,11(16) :3599.
  • 9Rebeck GW, Cheung BS, Growdon WB, et al. Lack of independent association of apolipoprotein E promoter and intron 1 polymorphisms with Alzehiemer's disease. Neurosci Lett, 1999,272(3): 155.
  • 10Wang JC, Kwon JM, Shah P, et al. Effect of ApoE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology, 2000, 55(11):1644.

共引文献38

同被引文献44

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部